Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Sentynl Therapeutics, Inc.

Clinical trials sponsored by Sentynl Therapeutics, Inc., explained in plain language.

Not yet finished but already full! 2
Sort by
  • New hope for kids with rare copper deficiency disease

    Disease control APPROVED_FOR_MARKETING

    This program gives children under 6 with Menkes disease access to copper histidinate injections. Menkes disease is a rare genetic disorder where the body cannot properly use copper, leading to severe developmental problems. The treatment aims to supply the missing copper to help …

    Sponsor: Sentynl Therapeutics, Inc. • Aim: Disease control

    Last updated Jun 27, 2026 09:09 UTC

  • Researchers track menkes disease over time to unlock key insights

    Knowledge-focused Ongoing

    This study gathers long-term health information from up to 50 people with Menkes disease, a rare genetic disorder. The goal is to track survival and nervous system changes over time. No new treatments are being tested; instead, researchers are collecting data to better understand…

    Sponsor: Sentynl Therapeutics, Inc. • Aim: Knowledge-focused

    Last updated Jun 27, 2026 09:10 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space